Skip to content
healthcare.dev

Terlivaz

NDC 43825-200, Terlipressin, injection, powder, lyophilized, for solution, from Mallinckrodt Hospital Products Inc..

Product NDC
43825-200
Status
Listed
Labeler
Mallinckrodt Hospital Products Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022231
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43825-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERLIPRESSIN.85 mg/5mL

Pharmacologic classes

Vasopressin Receptor Agonist [EPC]; Vasopressin Receptor Agonists [MoA]

Package NDCNDC-11Package
43825-200-01438250200011 VIAL, SINGLE-DOSE in 1 CARTON (43825-200-01) / 5 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3a35b86c-f451-4fac-8499-43019e4da354

Use it

Look up 43825-200 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43825-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43825-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.